SABBY MANAGEMENT, LLC - AVEO PHARMACEUTICALS INC ownership

AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 66 filers reported holding AVEO PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.

Quarter-by-quarter ownership
SABBY MANAGEMENT, LLC ownership history of AVEO PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$79,000
-79.9%
10,815
-84.1%
0.02%
-80.0%
Q4 2020$393,000
+153.5%
68,092
+161.5%
0.08%
+226.1%
Q3 2020$155,000
-65.6%
26,039
-70.2%
0.02%
-74.4%
Q2 2020$450,000
+10.8%
87,319
-22.1%
0.09%
-46.7%
Q1 2020$406,000112,1550.17%
Other shareholders
AVEO PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
AIGH Capital Management LLC 2,556,600$11,990,0003.66%
Worth Venture Partners, LLC 585,168$2,744,0001.36%
Birchview Capital, LP 140,000$657,0000.42%
NEA Management Company, LLC 3,952,958$18,539,0000.38%
J. Goldman & Co LP 1,220,758$5,725,0000.32%
Opaleye Management Inc. 263,400$1,235,0000.26%
Sender Co & Partners, Inc. 92,026$432,0000.22%
X-Square Capital, LLC 92,283$433,0000.22%
XTX Topco Ltd 18,128$85,0000.05%
PURA VIDA INVESTMENTS, LLC 123,416$579,0000.02%
View complete list of AVEO PHARMACEUTICALS INC shareholders